The antiparkinson properties of amantadine in drug-induced parkinsonism.
D000293:Adolescent; D000328:Adult; D000547:Amantadine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010259:Paranoid Disorders / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010865:Pilot Projects; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000009:adverse effects